Skip to main content
. Author manuscript; available in PMC: 2022 Jun 10.
Published in final edited form as: Cancer. 2019 Sep 19;126(1):98–104. doi: 10.1002/cncr.32508

Figure 1. Intimal sarcoma patients treated with anthracycline-based regimens.

Figure 1.

Figure 1.

Figure 1.

Figure 1.

Kaplan-Meier curves for recurrence-free survival (A) and overall survival (B) in patients treated for localized disease with curative intent (n=24); progression-free survival (C) and overall survival (D) in patients treated for advanced disease with palliative intent (n=42).